Identification of 1H-pyrazolo[3,4-b]pyridine derivatives as novel and potent TBK1 inhibitors: design, synthesis, biological evaluation, and molecular docking study
出版年份 2022 全文链接
标题
Identification of 1H-pyrazolo[3,4-b]pyridine derivatives as novel and potent TBK1 inhibitors: design, synthesis, biological evaluation, and molecular docking study
作者
关键词
-
出版物
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
Volume 37, Issue 1, Pages 1411-1425
出版商
Informa UK Limited
发表日期
2022-05-19
DOI
10.1080/14756366.2022.2076674
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Design and synthesis of 1H-pyrazolo[3,4-b]pyridines targeting mitogen-activated protein kinase kinase 4 (MKK4) - A promising target for liver regeneration
- (2021) Bent Pfaffenrot et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- TBK1 Inhibitor Exerts Antiproliferative Effect on Glioblastoma Multiforme Cells
- (2021) Sarah A. Scuderi et al. ONCOLOGY RESEARCH
- TANK-binding kinase 1 (TBK1): An emerging therapeutic target for drug discovery
- (2021) Shuang Xiang et al. DRUG DISCOVERY TODAY
- The kinase inhibitor BX795 suppresses the inflammatory response via multiple kinases
- (2020) Tao Yu et al. BIOCHEMICAL PHARMACOLOGY
- Targeting TANK-binding kinase 1 (TBK1) in cancer
- (2020) Or-Yam Revach et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Discovery of GSK8612, a Highly Selective and Potent TBK1 Inhibitor
- (2019) Douglas W. Thomson et al. ACS Medicinal Chemistry Letters
- Expression and prognostic role of IKBKE and TBK1 in stage I non-small cell lung cancer
- (2019) Xin Wang et al. Cancer Management and Research
- Ultrastructure of Human Pancreatic Cancer Cells Treated with a TBK1 Inhibitor
- (2019) Linda Yasui et al. MICROSCOPY AND MICROANALYSIS
- Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor
- (2019) Julien Lefranc et al. JOURNAL OF MEDICINAL CHEMISTRY
- TANK-Binding Kinase 1-Dependent Responses in Health and Autoimmunity
- (2018) Cynthia Louis et al. Frontiers in Immunology
- Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma
- (2017) Banu Eskiocak et al. Cancer Discovery
- Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
- (2017) Russell W. Jenkins et al. Cancer Discovery
- TBK1 Promote Bladder Cancer Cell Proliferation and Migration via Akt Signaling
- (2017) Wei Chen et al. Journal of Cancer
- Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing
- (2016) Qi Chen et al. NATURE IMMUNOLOGY
- Autophagy Inhibition Dysregulates TBK1 Signaling and Promotes Pancreatic Inflammation
- (2016) S. Yang et al. Cancer Immunology Research
- TBK1 inhibitors: a review of patent literature (2011 – 2014)
- (2015) Tao Yu et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Pharmacological Inhibition of ULK1 Kinase Blocks Mammalian Target of Rapamycin (mTOR)-dependent Autophagy
- (2015) Katy J. Petherick et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Evaluating TBK1 as a Therapeutic Target in Cancers with Activated IRF3
- (2014) Asli Muvaffak et al. MOLECULAR CANCER RESEARCH
- Elevated expression of TANK-binding kinase 1 enhances tamoxifen resistance in breast cancer
- (2014) Congwen Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanism of Endogenous Regulation of the Type I Interferon Response by Suppressor of IκB Kinase ϵ (SIKE), a Novel Substrate of TANK-binding Kinase 1 (TBK1)
- (2013) James D. Marion et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structure and Ubiquitination-Dependent Activation of TANK-Binding Kinase 1
- (2013) Daqi Tu et al. Cell Reports
- Crystal Structure and Mechanism of Activation of TANK-Binding Kinase 1
- (2013) Amede Larabi et al. Cell Reports
- Novel cross-talk within the IKK family controls innate immunity
- (2011) Kristopher Clark et al. BIOCHEMICAL JOURNAL
- Emerging roles for the non-canonical IKKs in cancer
- (2010) R R Shen et al. ONCOGENE
- Use of the Pharmacological Inhibitor BX795 to Study the Regulation and Physiological Roles of TBK1 and IκB Kinase ϵ
- (2009) Kristopher Clark et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- (2009) David A. Barbie et al. NATURE
- Advances in Targeting IKK and IKK-Related Kinases for Cancer Therapy
- (2008) D.-F. Lee et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search